Research Article
Assessing the Risk of Birth Defects Associated with Exposure to Fixed-Dose Combined Antituberculous Agents during Pregnancy in Rats
Table 3
Gross pathological (morphology) results of fetuses of treated animals.
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ORG: organogenesis. Group 1: control group. Group 2: administered with clinical dose (51.4 mg/kg/day) of fixed-dose combined antituberculous agents. Group 3: administered with clinical dose of fixed-dose combined antituberculous agents plus 10 mg/kg/day of Vitamin C. |